In This Article:
As the German market navigates a landscape marked by geopolitical tensions and economic shifts, the DAX index recently experienced a decline of 1.81%, reflecting broader investor caution across Europe. In this context, growth companies with high insider ownership can offer unique insights into potential resilience and strategic vision, as insiders' stakes often signal confidence in long-term prospects.
Top 10 Growth Companies With High Insider Ownership In Germany
| Name | Insider Ownership | Earnings Growth |
| Stemmer Imaging (XTRA:S9I) | 25% | 23.2% |
| Exasol (XTRA:EXL) | 25.3% | 117.1% |
| Deutsche Beteiligungs (XTRA:DBAN) | 39.5% | 54.1% |
| adidas (XTRA:ADS) | 16.6% | 41.8% |
| pferdewetten.de (XTRA:EMH) | 20.6% | 97.9% |
| Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
| Beyond Frames Entertainment (DB:8WP) | 10.8% | 112.2% |
| R. STAHL (XTRA:RSL2) | 37.9% | 59.3% |
| Your Family Entertainment (DB:RTV) | 17.3% | 124.4% |
| elumeo (XTRA:ELB) | 25.8% | 118.1% |
Underneath we present a selection of stocks filtered out by our screen.
Brockhaus Technologies
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Brockhaus Technologies AG is a private equity firm with a market capitalization of €297.76 million.
Operations: The company's revenue is primarily derived from its Financial Technologies segment, generating €174.59 million, followed by the Security Technologies segment with €37.03 million.
Insider Ownership: 26.6%
Brockhaus Technologies, with significant insider ownership, is positioned for growth despite recent challenges. The company forecasts revenue between €220 million and €240 million in 2024, increasing to €290 million-€320 million in 2025. Although it reported a net loss of €6.65 million for H1 2024, earnings are expected to grow at an impressive rate of 93% annually over the next three years, outperforming the broader German market's growth expectations.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates as an online pharmacy across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.79 billion.
Operations: The company's revenue is derived from two main segments: DACH, contributing €1.74 billion, and International, accounting for €391 million.
Insider Ownership: 17.4%
Redcare Pharmacy, with substantial insider ownership, is poised for growth despite a challenging past year. The company recently raised its 2024 sales guidance to between €2.35 billion and €2.5 billion, reflecting confidence in its trajectory. While it reported a net loss of €12.07 million for H1 2024, earnings are forecast to grow by 54.29% annually over the next three years, outpacing the German market's revenue growth rate of 5.4%.